Form 4: Fulgent Genetics Chief Scientific Officer Sells Shares for Tax Obligations
Insider Transaction Report
Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, reported the sale of 1,039 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.
Summary
- Hanlin Gao, Chief Scientific Officer of Fulgent Genetics, Inc. (FLGT), reported two transactions involving the sale of common stock.
- On May 27, 2025, Mr. Gao sold 383 shares of Fulgent Genetics common stock at a weighted-average price of $20.5753 per share.
- Also on May 27, 2025, an additional 656 shares of common stock were sold at a weighted-average price of $20.5169 per share.
- Both sales were conducted to satisfy tax withholding obligations arising from the vesting of restricted stock units (RSUs) granted on February 23, 2023, and February 26, 2024, respectively.
- Following these transactions, Mr. Gao beneficially owns 962,035 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: The filing reports a routine, non-discretionary sale of shares by an insider to cover tax obligations related to RSU vesting. This is a common occurrence and does not typically indicate a change in sentiment towards the company's prospects.
Future Outlook
N/A. This document does not provide future outlook or guidance.
Industry Context
N/A. This filing is specific to an insider transaction and does not provide broader industry context.
Stakeholder Impact
- Shareholders: Minimal impact, as the sales are routine and for tax purposes, not indicative of a lack of confidence. The number of shares sold is small relative to the total shares outstanding and the insider's remaining holdings.
Key Dates
| Date | Description |
|---|---|
| February 23, 2023 | Grant date of certain restricted stock units (RSUs) to the reporting person. |
| February 27, 2023 | Date of original Form 4 filing reporting the RSU grants from February 23, 2023. |
| February 26, 2024 | Grant date of certain restricted stock units (RSUs) to the reporting person. |
| February 28, 2024 | Date of original Form 4 filing reporting the RSU grants from February 26, 2024. |
| May 27, 2025 | Date of reported stock sales by Hanlin Gao. |
| May 28, 2025 | Signature date of the Form 4 filing. |
Keywords
Fulgent Genetics, FLGT, Form 4, insider transaction, stock sale, RSU vesting, tax withholding, Hanlin Gao, Chief Scientific Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.